These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27228585)

  • 21. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life with PCI versus medical therapy in stable coronary disease.
    Reppel M; Radke PW; Schunkert H
    N Engl J Med; 2008 Nov; 359(21):2290-1; author reply 2292. PubMed ID: 19031542
    [No Abstract]   [Full Text] [Related]  

  • 23. Quality of life with PCI versus medical therapy in stable coronary disease.
    Smith J
    N Engl J Med; 2008 Nov; 359(21):2291-2; author reply 2292-3. PubMed ID: 19031545
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical management of stable angina and unstable angina in the elderly with coronary artery disease.
    Olson HG; Aronow WS
    Clin Geriatr Med; 1996 Feb; 12(1):121-40. PubMed ID: 8653654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined treatment of coronary heart disease with diltiazem and isosorbide dinitrate].
    Beythien RD
    Dtsch Med Wochenschr; 1983 Feb; 108(5):176-80. PubMed ID: 6402353
    [No Abstract]   [Full Text] [Related]  

  • 26. [Coronary sclerosis and angina pectoris. Clinical, double-blind study using Stenoptin].
    Müller R
    MMW Munch Med Wochenschr; 1978 Jun; 120(24):843-4. PubMed ID: 351379
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
    Ruzyllo W; Szwed H; Sadowski Z; Elikowski W; Grzelak-Szafranska H; Orszulak W; Szymczak K; Winter M
    Curr Med Res Opin; 2004 Sep; 20(9):1447-54. PubMed ID: 15383193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of stable angina pectoris. "Mother Courage and her children"].
    Nagy V; Czuriga I
    Orv Hetil; 2008 Feb; 149(7):291. PubMed ID: 18258558
    [No Abstract]   [Full Text] [Related]  

  • 29. Quality of life with PCI versus medical therapy in stable coronary disease.
    Beltrame JF; Tavella R; Cutri N
    N Engl J Med; 2008 Nov; 359(21):2289-90; author reply 2292. PubMed ID: 19020332
    [No Abstract]   [Full Text] [Related]  

  • 30. Ivabradine in combination with a beta-blocker. Stable angina: do not use instead, of or, with a beta-blocker.
    Prescrire Int; 2010 Dec; 19(111):279. PubMed ID: 21370517
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.
    Tendera M; Borer JS; Tardif JC
    Cardiology; 2009; 114(2):116-25. PubMed ID: 19468225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
    Szwed H; Sadowski Z; Elikowski W; Koronkiewicz A; Mamcarz A; Orszulak W; Skibińska E; Szymczak K; Swiatek J; Winter M
    Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment and prevention of ischemic heart disease].
    Ivanova TIu
    Feldsher Akush; 1983; 48(6):27-31. PubMed ID: 6557030
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of angina pectoris with metoprolol. A comparison between Durules administered once daily and tablets administered twice daily.
    Orö L
    Ann Clin Res; 1981; 13 Suppl 30():58-60. PubMed ID: 6794419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of PCI on quality of life in patients with stable coronary disease.
    Weintraub WS; Spertus JA; Kolm P; Maron DJ; Zhang Z; Jurkovitz C; Zhang W; Hartigan PM; Lewis C; Veledar E; Bowen J; Dunbar SB; Deaton C; Kaufman S; O'Rourke RA; Goeree R; Barnett PG; Teo KK; Boden WE; ; Mancini GB
    N Engl J Med; 2008 Aug; 359(7):677-87. PubMed ID: 18703470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differential therapeutic aspects in the use of drugs that reduce preload and/or afterload in coronary heart disease].
    Klaus W; Bassenge E; Böhme E; Drebinger K; Gilfrich HJ; Grewe R; Hellige G; Krüger R; Lossnitzer K; Simon H
    Med Klin (Munich); 1987 Jan; 1():33-8. PubMed ID: 3472030
    [No Abstract]   [Full Text] [Related]  

  • 37. [Collateral coronary blood circulation and its role in the mechanism of the anti-ischemic (antianginal) action of pharmacologic preparations].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1989; 52(2):15-24. PubMed ID: 2663540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current developments in the treatment of unstable angina pectoris and acute myocardial infarct].
    Vlaicu R; Olinic N
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(2):117-28. PubMed ID: 2908073
    [No Abstract]   [Full Text] [Related]  

  • 39. [The combination preparation VisanoCor in patients with angina pectoris with special monitoring of urinary catecholamines].
    Hagel H
    Fortschr Med; 1981 Nov; 99(41):1714-7. PubMed ID: 7319440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life with PCI versus medical therapy in stable coronary disease.
    Rodriguez AE; Maree AO; Palacios IF
    N Engl J Med; 2008 Nov; 359(21):2290; author reply 2292. PubMed ID: 19031541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.